Stay updated on Elranatamab Combo in Myeloma Clinical Trial

Sign up to get notified when there's something new on the Elranatamab Combo in Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Elranatamab Combo in Myeloma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page now shows a generic error page (An error occurred) instead of the study record, indicating the study content is currently unavailable.
    Difference
    19%
    Check dated 2026-08-09T12:00:31.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Added Multiple myeloma to the related topics section and included MedlinePlus Genetics as a related topic; updated the site revision tag from v3.6.3 to v3.6.4.
    Difference
    0.1%
    Check dated 2026-07-26T00:10:36.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    No textual changes were detected for this page based on the tracked changes data.
    Difference
    0.0%
    Check dated 2026-07-18T20:49:44.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The study locations list was updated with multiple new sites across the UK, New Zealand, Brazil, Austria, Belgium, and other regions, bringing the total number of locations to 127. A previously listed site at Memorial Sloan Kettering Cancer Center - Main Campus in New York was removed.
    Difference
    2%
    Check dated 2026-07-11T17:21:18.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The page shows an updated revision label from v3.6.2 to v3.6.3, indicating a small maintenance update. This change does not affect the study information or how users interact with the page.
    Difference
    0.0%
    Check dated 2026-07-04T13:37:39.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    The Locations section was updated to include additional recruitment sites across multiple countries, and the total number of locations is shown as 121, indicating expanded geographic accessibility for the trial.
    Difference
    1%
    Check dated 2026-06-27T06:18:21.000Z thumbnail image

Stay in the know with updates to Elranatamab Combo in Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Elranatamab Combo in Myeloma Clinical Trial page.